358 related articles for article (PubMed ID: 28878842)
1. Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.
Lindsay CD; Kostiuk MA; Harris J; O'Connell DA; Seikaly H; Biron VL
Clin Epigenetics; 2017; 9():95. PubMed ID: 28878842
[TBL] [Abstract][Full Text] [Related]
2. Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer.
Idris S; Lindsay C; Kostiuk M; Andrews C; Côté DW; O'Connell DA; Harris J; Seikaly H; Biron VL
J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):54. PubMed ID: 27793210
[TBL] [Abstract][Full Text] [Related]
3. Investigating Trk Protein Expression between Oropharyngeal and Non-oropharyngeal Squamous Cell Carcinoma: Clinical Implications and Possible Roles of Human Papillomavirus Infection.
Cho YA; Chung JM; Ryu H; Kim EK; Cho BC; Yoon SO
Cancer Res Treat; 2019 Jul; 51(3):1052-1063. PubMed ID: 30360033
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation.
Gannon OM; Merida de Long L; Endo-Munoz L; Hazar-Rethinam M; Saunders NA
Clin Cancer Res; 2013 Jan; 19(2):428-41. PubMed ID: 23186778
[TBL] [Abstract][Full Text] [Related]
5. Chromatin structure regulates cancer-specific alternative splicing events in primary HPV-related oropharyngeal squamous cell carcinoma.
Guo T; Zambo KDA; Zamuner FT; Ou T; Hopkins C; Kelley DZ; Wulf HA; Winkler E; Erbe R; Danilova L; Considine M; Sidransky D; Favorov A; Florea L; Fertig EJ; Gaykalova DA
Epigenetics; 2020 Sep; 15(9):959-971. PubMed ID: 32164487
[TBL] [Abstract][Full Text] [Related]
6. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinomas.
Biron VL; Mohamed A; Hendzel MJ; Alan Underhill D; Seikaly H
J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S65-70. PubMed ID: 22569052
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity to inhibition of DNA repair by Olaparib in novel oropharyngeal cancer cell lines infected with Human Papillomavirus.
Pirotte EF; Holzhauser S; Owens D; Quine S; Al-Hussaini A; Christian AD; Giles PJ; Man ST; Evans M; Powell NG
PLoS One; 2018; 13(12):e0207934. PubMed ID: 30543656
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV-positive oropharyngeal squamous cell carcinoma.
Schlecht NF; Ben-Dayan M; Anayannis N; Lleras RA; Thomas C; Wang Y; Smith RV; Burk RD; Harris TM; Childs G; Ow TJ; Prystowsky MB; Belbin TJ
Cancer Med; 2015 Mar; 4(3):342-53. PubMed ID: 25619363
[TBL] [Abstract][Full Text] [Related]
10. Morphoproteomics, E6/E7 in-situ hybridization, and biomedical analytics define the etiopathogenesis of HPV-associated oropharyngeal carcinoma and provide targeted therapeutic options.
Brown RE; Naqvi S; McGuire MF; Buryanek J; Karni RJ
J Otolaryngol Head Neck Surg; 2017 Aug; 46(1):52. PubMed ID: 28818106
[TBL] [Abstract][Full Text] [Related]
11. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
Jouhi L; Datta N; Renkonen S; Atula T; Mäkitie A; Haglund C; Ahmed A; Syrjänen S; Grénman R; Auvinen E; Lehtonen S; Hagström J
Tumour Biol; 2015 Sep; 36(10):7755-64. PubMed ID: 25941114
[TBL] [Abstract][Full Text] [Related]
12. Oropharyngeal cancers: relationship between epidermal growth factor receptor alterations and human papillomavirus status.
Mirghani H; Amen F; Moreau F; Guigay J; Hartl DM; Lacau St Guily J
Eur J Cancer; 2014 Apr; 50(6):1100-11. PubMed ID: 24424107
[TBL] [Abstract][Full Text] [Related]
13. MMP9, Cyclin D1 and β-Catenin Are Useful Markers of p16-positive Squamous Cell Carcinoma in Therapeutic EGFR Inhibition In Vitro.
Umbreit C; Erben P; Faber A; Hofheinz RD; Aderhold C; Weiss C; Hoermann K; Wenzel A; Schultz JD
Anticancer Res; 2015 Jul; 35(7):3801-10. PubMed ID: 26124325
[TBL] [Abstract][Full Text] [Related]
14. Relationship between insulin-like growth factor-1 receptor and human papillomavirus in patients with oropharyngeal cancer.
Matsumoto F; Fujimaki M; Ohba S; Kojima M; Yokoyama J; Ikeda K
Head Neck; 2015 Jul; 37(7):977-81. PubMed ID: 24700733
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma.
van Kempen PM; Noorlag R; Braunius WW; Moelans CB; Rifi W; Savola S; Koole R; Grolman W; van Es RJ; Willems SM
Cancer Med; 2015 Oct; 4(10):1525-35. PubMed ID: 26194878
[TBL] [Abstract][Full Text] [Related]
17. Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes.
Nakagawa T; Matsusaka K; Misawa K; Ota S; Fukuyo M; Rahmutulla B; Kunii N; Sakurai D; Hanazawa T; Matsubara H; Okamoto Y; Kaneda A
Int J Cancer; 2020 May; 146(9):2460-2474. PubMed ID: 31997344
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Ezh2 In Vitro and the Decline of
Hong F; Zhao M; Zhang L; Feng L
Stem Cells Dev; 2019 May; 28(10):649-658. PubMed ID: 30887911
[TBL] [Abstract][Full Text] [Related]
19. DNA-Pk
Weaver AN; Cooper TS; Wei S; Carroll WR; Rosenthal EL; Yang ES
Head Neck; 2017 Feb; 39(2):206-214. PubMed ID: 27507640
[TBL] [Abstract][Full Text] [Related]
20. Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation.
Mochizuki D; Misawa Y; Kawasaki H; Imai A; Endo S; Mima M; Yamada S; Nakagawa T; Kanazawa T; Misawa K
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
